MetaTOC stay on top of your field, easily

Exploring the molecular classification-based personalized treatment decision-making in FIGO stage I–III endometrial carcinoma after surgery: a population-based real-world study

, , , , , , , ,

Therapeutic Advances in Medical Oncology

Published online on

Abstract

Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Background:Robust real-world evidence supporting the clinical utility of molecular classification in endometrial carcinoma (EC) remains limited.Objectives:To investigate the molecular classification-based personalized treatment decision-making for EC by ...